| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000011975 |
| Receipt No. | R000013989 |
| Scientific Title | Evaluation of optimal dosage of anesthetic |
| Date of disclosure of the study information | 2013/10/10 |
| Last modified on | 2020/03/10 (Ver. 11) |
| Basic information | ||
| Public title | Evaluation of optimal dosage of anesthetic | |
| Acronym | Evaluation of optimal dosage of anesthetic | |
| Scientific Title | Evaluation of optimal dosage of anesthetic | |
| Scientific Title:Acronym | Evaluation of optimal dosage of anesthetic | |
| Region |
|
|
| Condition | ||
| Condition | arteriosclerosis obliterans
ischemic heart disease valvular disease aneurysm of the aorta |
|
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the optimal dosage of propofol and remifentanil at induction of anesthesia |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | blood pressure |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | remifentanil1.0ug/kg/min,propofol2ug/ml
|
|
| Interventions/Control_2 | remifentanil0.5ug/kg/min,propofol2ug/ml | |
| Interventions/Control_3 | remifentanil0.5ug/kg/min,propofol3ug/ml | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who were scheduled to undergo peripheral vascular bypass surgery for arteriosclerosis obliterans and patients who were scheduled to undergo cardiovascular surgery(coronary artery bypass grafting, valve replacement, or replacement of the aorta) | |||
| Key exclusion criteria | arrhythmia
heart failure(EF<30%) |
|||
| Target sample size | 45 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of Anesthesiology&Critical care | ||||||
| Zip code | |||||||
| Address | Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido | ||||||
| TEL | 0166682583 | ||||||
| toyama12@asahikawa-med.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Asahikawa Medical University | ||||||
| Division name | Department of Anesthesiology&Critical care | ||||||
| Zip code | |||||||
| Address | Midorigaoka-higashi 2-1-1-1, Asahikawa, Hokkaido | ||||||
| TEL | 0166682583 | ||||||
| Homepage URL | |||||||
| toyama12@asahikawa-med.ac.jp | |||||||
| Sponsor | |
| Institute | Asahikawa Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013989 |